May 15, 2014 – Dr. Yuzhuo Wang, dual appointed Senior Scientist at the Vancouver Prostate Centre and BC Cancer Agency, tenured faculty member of the Department of Urologic Sciences at the University of British Columbia and founder of the Living Tumour Laboratory has officially joined our Scientific Advisory Board. Dr. Wang is recognized for his […]
In preparation for our FDA submission for Phase I Human Trials, Biopep is excited to report that we have contracted with BRI Biopharmaceuticals Research Inc. to further analyze the intrinsic qualities of LSE. This study will include an in-depth analysis of: LSE drug consistency LSE drug efficacy including protein marker selection LSE drug safety including […]
Dr. David Kwok, the founder and president of BRI Biopharmaceutical Research Inc., has officially joined our Scientific Advisory Board. Dr. Kwok is a specialist in integrated pre-clinical development of biological products; he has held numerous managerial and scientific positions with Health Canada involving botanical natural health products quality control, antimicrobial drug resistance and veterinary drug […]